Prudential Financial
BIVV

Prudential Financial’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Prudential Financial’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,019,132
Closed -$55M – 2407
2017
Q4 		$55M Buy
1,019,132
+144,096
+16% +$7.88M 0.07% 297
2017
Q3 		$49.9M Buy
875,036
+185,700
+27% +$10.9M 0.07% 306
2017
Q2 		$41.5M Buy
689,336
+550,352
+396% +$31.3M 0.06% 364
2017
Q1 		$7.57M Buy
+138,984
New +$6.85M 0.01% 963

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Prudential Financial's BIVV Position: Q1 2018 in Review

Prudential Financial sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 1,019,132 shares — an estimated $55M sold.

Prudential Financial first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $55M in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Prudential Financial reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Prudential Financial sold 1,019,132 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $55M.
  • Prudential Financial first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Prudential Financial's Bioverativ Inc. Common Stock position peaked at $55M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Prudential Financial's 13F filing for Q1 2018, filed 4 May 2018.